# Gyre Therapeutics, Inc.: Form 8-K, filed May 9, 2025

- Company: [Gyre Therapeutics, Inc.](/companies/gyre.md) (CIK 1124105)
- Form: 8-K
- Filed: 2025-05-09
- Accepted by EDGAR: May 9, 2025, 00:30 ET
- Period: 2025-05-09
- Accession: 0000950170-25-067452
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1124105/000095017025067452/gyre-20250509.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1124105/000095017025067452/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1124105/000095017025067452/gyre-20250509.htm

Filed May 9, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-067452. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.